Cargando…
Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study
Metabotropic glutamate receptors (mGluRs) have been proposed as promising therapeutic targets to correct the dysregulated glutamate signaling, associated with neurodegenerative pathologies. Of all mGluR subtypes, especially mGluR5 acts as a modulator of glutamate-induced excitotoxicity. To study the...
Autores principales: | Crabbé, Melissa, Dirkx, Nina, Casteels, Cindy, Laere, Koen Van |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733799/ https://www.ncbi.nlm.nih.gov/pubmed/31501497 http://dx.doi.org/10.1038/s41598-019-49356-x |
Ejemplares similares
-
Neuronal metabotropic glutamate receptor 8 protects against neurodegeneration in CNS inflammation
por: Woo, Marcel S., et al.
Publicado: (2021) -
Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington’s Disease: a Longitudinal PET Study
por: Bertoglio, Daniele, et al.
Publicado: (2020) -
Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An in vitro Study
por: Zimmermann, Maria, et al.
Publicado: (2022) -
Metabotropic glutamate receptors inhibit microglial glutamate release
por: McMullan, Stephen M, et al.
Publicado: (2012) -
Optical Control of Metabotropic Glutamate Receptors
por: Levitz, Joshua, et al.
Publicado: (2013)